Fresenius Medical Care | FME - Cost Of Sales


Fresenius Medical Care reported EUR3.43B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Akzo Nobel EUR 1.41B 28M Mar/2026
Alcon AG USD 1.18B 26M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
DaVita Healthcare Partners USD 2.52B 76.13M Mar/2026
Demant DKK 2.89B 188M Dec/2025
E.ON EUR 16.41B 114M Mar/2026
Essilor EUR 6.06B 741M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Genmab DKK 81M 23M Dec/2025
Getinge SEK 6.02B 1.7B Dec/2024
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
GRIFOLS EUR 1.08B 214.82M Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Lonza CHF 2.28B 189M Jun/2025
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
RWE EUR 3.21B 397M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026
SAP EUR 2.58B 20M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025